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Abstract: 
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen 
receptor positive operable breast cancer in some older women. However the decision to offer 
PET involves complex trade-offs and is influenced by both patient choice and healthcare 
professional (HCP) preference. This study aimed to compare the views of patients and HCPs 
about this decision and explore decision making (DM) preferences and whether these are 
taken into account during consultations. 
Methods: This multicentre, UK, mixed methods study had 3 components: (1) questionnaires 
to older women undergoing counselling about breast cancer treatment options which assessed 
their DM preferences and realities; (2) qualitative interviews with older women with operable 
breast cancer offered a choice of either surgery or PET and (3) qualitative interviews with 
HCPs (both of which focused on DM preferences in this setting). 
Results: Thirty-three patients and 34 HCPs were interviewed. A range of opinions about 
patient involvement in DM were identified.  Patients indicated varying preferences for DM 
involvement which were variably taken into account by HCPs. These qualitative findings 
were broadly supported by the questionnaire results. Most patients (536/729; 73.5%) 
achieved their preferred DM style, however the remainder felt that their DM preferences had 
not been taken into consideration. 
Conclusions:  These results suggest that whilst many older women achieve their desired 
level of DM engagement, some do not, raising the possibility that they may be making 
choices which are not concordant with their treatment preferences.  
Key words: 
Cancer, primary endocrine therapy, oncology, elderly, decision-making.  
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Background. 
Breast cancer in the older population represents a significant problem, with around one third 
of all new diagnoses occurring in the over 70s in the UK [1]. The “standard” treatment for 
breast cancer is surgery, but as age increases, so does co-morbidity and frailty, resulting in 
reduced tolerance to surgery and other breast cancer therapies [2]. Additionally, life-
expectancy decreases with age [3] and co-morbidity increases [4] so that other-cause 
mortality outweighs breast-cancer mortality, thereby decreasing the potential benefit of 
surgery [5,6]. Consequently, older women with operable breast cancer may be offered 
alternative treatments, such as Primary Endocrine Therapy (PET) where women with 
oestrogen receptor positive (ER+) breast cancers are treated with endocrine therapy alone. 
PET is an effective treatment for some older women, with a Cochrane review demonstrating 
no difference in overall survival when compared to surgery [7]. However local control rates 
are superior in surgically treated patients, with disease progression sometimes necessitating a 
change of management in patients treated with PET [8-10]. 
There is wide variation in PET use in the UK; rates ranging from 12%-40% in different 
regions [11]. Whilst some of this may be due to case mix variation, studies have shown that 
this does not account for all of the variation [12,13] and patient preference for non-surgical 
therapy is often reported as a major factor in determining PET treatment in older patients [14-
16]. However, other studies suggest that patient choice alone is unlikely to be the only cause 
of lower UK surgery rates [17], with clinician preference and how treatment options are 
presented also being significant in determining treatment [18].  
Shared DM is increasingly considered to be relevant in preference sensitive health care 
decisions with patients and HCPs working together to make health care decisions that are 
based on clinical evidence and patients’ informed preferences [19-21]. However there is 
evidence to suggest that not all older patients want to engage in shared DM, instead 
preferring to simply receive information [22] and accept a doctor-led DM process [23-26].  
Currently little is known about the influence of HCP opinion on DM in older women with 
operable breast cancer. This study aimed to explore the interaction between HCPs and older 
patients in the DM process, as well as the concordance between HCP and patient views 
regarding the process of DM about treatment of operable breast cancer.  
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Methods: 
Study Design:  
This study is a convergent mixed methods study with 3 components, where data were 
collected concurrently and findings were integrated following independent analysis: 
1. Questionnaires about DM style administered to a large cohort of older women 
recruited as part of a multicentre UK cohort study of older women with breast cancer 
(the Bridging the Age Gap in Breast Cancer study). 
2. Interviews with older women previously diagnosed with operable, ER+ breast cancer, 
to explore their DM preferences about the choice between surgery or PET 
3. Interviews with HCPs involved in the care of older women with breast cancer to 
explore their views about older women’s involvement in DM 
This type of study design was chosen so the qualitative interviews would provide a more in-
depth insight into the quantitative findings obtained from the cohort study. 
 
1. DM preferences questionnaire. 
This was a prospective observational cohort study of women aged over 70 years diagnosed 
with operable primary breast cancer in 43 UK units since February 2013. Recruitment for this 
trial is ongoing, and results presented here represent an interim analysis of the first 729 
patients with available data. Data were collected on patient and tumour characteristics, 
treatment type, as well as the patients’ preferred and actual DM styles for their breast cancer 
treatment using a widely used validated instrument [27,28] (Table 1). The DM preferences 
questionnaire was applied within 4 weeks of diagnosis and prior to treatment. DM styles 
were then classified into three categories: Patient-centred, Shared and Doctor-centred (Table 
1). 
 
2. Patient Interviews. 
Semi-structured interviews were undertaken with patients across five of the UK breast units 
recruiting to the Age Gap cohort study to explore opinions on treatment DM styles and 
preferences between April-December 2013. Eligibility criteria were: age 75 or over with 
operable breast cancer, diagnosed within the previous 5 years and offered a documented 
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choice of either surgery or PET at initial diagnosis. Interviews and analysis were undertaken 
by one of two experienced qualitative researchers (KL/MB). The interview schedule focused 
on DM preferences and experiences of the DM process. Interviews were digitally recorded 
and transcribed verbatim. Recruitment ceased once data saturation had occurred.   
 
3.  HCP Interviews. 
Interviews were undertaken with HCPs (surgeons, nurse specialists or geriatricians working 
with older breast cancer patients) recruited across 14 of the UK breast units recruiting to the 
cohort study to explore their opinions on treatment DM styles. Interviews were conducted 
between January-November 2013, by JM and participants were purposively selected from 
regions with high and low PET rates according to UK national audit data [11].  Interviews 
were digitally recorded and transcribed verbatim.  Recruitment ceased once data saturation 
had occurred.   
 
Data Analysis: 
Questionnaires: 
Statistical analyses were performed using IBM SPSS statistical package, version 21. 
Concordance between preferred and actual DM preferences was assessed using Kappa, and 
associations between age, treatment and DM style identified using Chi-squared tests. 
Statistical significance was taken at p<0.05.  
Interviews: 
Framework analysis [29], involving five steps of familiarisation, theme development, 
indexing, charting, and interpretation, was used. Analysis of patient interviews was 
undertaken by MB/KL with supplemental feedback undertaken by lay patient representatives.  
Analysis of HCP interviews was conducted by JM with 10% of transcripts double-coded by 
MB. Initial DM themes from both sets of interviews where compared and contrasted by two 
researchers (JM/MB). 
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Ethics and Research Governance:  
The study protocols were approved by the UK National Research Ethics Committee and 
institutional approvals were granted at each site (12/LO/1808, 12/LO/1722 & SMBRER243). 
All patients and HCPs gave written informed consent.    
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Results: 
Questionnaires: 
Data on DM styles and treatment were available for 729 patients (age range 70-96 years; 
median 77 years), of whom 594 had undergone surgery and 135 had been treated with PET. 
Both preferred and actual DM styles were associated with final treatment type, with surgery 
being associated with more doctor-centred treatment decisions and PET with more patient-
centred decisions (p<0.001 and p=0.004 respectively; Figure 1). There was moderate 
agreement between patients’ preferred and actual DM style (Kappa = 0.60, p<0.001) with 
536/729 (73.5%) achieving their preferred DM style (Table 2). Increasing age was also 
associated with more patient-centred DM styles, both preferred and actual (p<0.001). 
Interviews: 
Patient interviews were undertaken with 33 older women with breast cancer (median age 83, 
range 75-94 years), who were a median of 20 months (range 3 to 60) from diagnosis. Twenty-
two women received PET and 11 surgery. Interview duration was a median of 57 (range 23 to 
85) minutes. 
Healthcare professional interviews were undertaken with 34 HCPs (20 surgeons, 13 breast 
care nurses (BCNs), and 1 geriatrician). Twenty-one (62%) were from high PET rate units, 
with the remaining 13 (38%) from low PET rate units. Interview duration was a median of 33 
(range 16 to 55) minutes. 
Combined interview analysis categorised the data into three themes pertaining to the 
treatment DM of older women with operable breast cancer: 
1. Patient involvement in DM 
2. Influence of HCP on DM 
3. DM processes 
 
Theme 1: Patient involvement in DM 
Healthcare professionals varied on their opinions regarding the DM styles of older women; 
some believing that older patients preferred a more doctor-centred approach whilst others felt 
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they utilised a more patient-centred DM approach. Patients also tended to fit into one of these 
categories (Table 3, Subtheme 1b). Patients who had a more patient-centred approach 
described having already made their mind up about treatment before discussing options with 
their HCP. Overall, most patients (n=29) were satisfied with their involvement in the DM 
process. 
Patients’ preconceived ideas about themselves, breast cancer and cancer treatments were 
identified by both HCPs and patients as factors that influenced their treatment preference. 
Particular issues raised included the belief that they were too old for treatment (particularly 
surgery), the notion that quality of life was prioritised over quantity, and the impact of 
previous experiences of cancer, either themselves or of family and friends (Table 3, 
Subtheme 1a).  
 
Theme 2: Influence of HCP on DM 
Both HCPs and patients felt that the HCP had significant influence over patient DM when 
offered a treatment choice (Table 3, Subtheme 2a). Indeed, some women (n=8) described 
situations where the HCP tried to change their mind regarding their treatment choice (Table 
3, Subtheme 2a). Not all HCPs (n=5) felt that patients should be offered a choice of surgery 
or PET and this was mirrored by some patients (n=7) who felt they had not been given a 
treatment option (Table 3, Subtheme 2b). 
Several patients (n=12) stated that they wanted a recommendation from their HCP about 
treatment. Willingness to recommend varied, with most (n=25) quite happy to advise patients 
and others (n=5) feeling very uncomfortable about making recommendations (Table 3, 
Subtheme 2c). 
 
Theme 3: DM processes 
Giving patient’s time to reach a treatment decision was viewed as important by HCPs. 
However, some patients (n=5) felt they had been expected to make a decision quickly, despite 
HCPs encouraging them to take time to consider their options. Others (n=12) described an 
internal desire to get the DM process “over with” (Table 3, Subtheme 3a). Both groups felt 
that the BCNs played a major role in helping patients decide (Table 3, Subtheme 3b). 
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Interestingly, there was a notion from HCPs that older patients generally did not require or 
want as much information regarding treatment compared to younger women, and this 
corresponded to some patients’ who felt overwhelmed by the volume of information they 
were given. A small number of patients (n=4) felt that the HCPs did not want to give them 
information (Table 3, Subtheme 3c). 
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Discussion: 
Despite the evidence suggesting older patients prefer a more passive, doctor-centred role in 
treatment DM [23-26], this study identified a range of preferred DM styles among older 
women with operable breast cancer and demonstrated the complex relationship between 
patients and their HCPs in the DM process. Vogel and colleagues explored the concordance 
between HCP and patient preference for DM in breast cancer patients and found that HCP 
perceptions were often inconsistent with patient preference [22]. Within this study, almost 
three-quarters of patients achieved their preferred DM style, suggesting that HCPs were 
utilising a more individualised approach to treatment DM. However, a quarter of patients did 
not achieve their preferred DM style, raising the possibility that they may be making choices 
which are not concordant with their treatment preferences.  
Treatment received was related to patient DM style, where women choosing PET generally 
had a more patient-centric DM experience compared to women treated with surgery. This 
suggests that a significant proportion of women treated with PET chose this treatment as a 
means of avoiding surgery. This is in line with other similar studies where patient choice is 
commonly stated as a reason why patients receive PET [14,16,30]. Interestingly, increasing 
age was also associated with more patient-centred DM styles, with those at the younger end 
of the age spectrum having more doctor-centred and shared DM styles. This may partly 
explain the increasing rates of PET in the oldest old, with HCPs perhaps feeling more 
inclined to stress the importance of surgery in the younger cohort, thus resulting in the 
perception of a doctor-centred decision. Additionally, some patients treated with PET may 
have been considered too frail to be offered surgery and so their treatment choice may have 
been PET vs. no treatment which could partly explain why they felt a patient-centred DM had 
been used. The findings of the present study are in contrast to findings by Lavelle and 
colleagues [17] who reported that lower rates of surgical treatment are unlikely to be due to 
patient choice. This may represent a difference in study population, with the study by Lavelle 
and colleagues recruiting patients mainly from one region in England in comparison to this 
study in which patients were recruited from a wider area. 
Hamaker and colleagues [18] suggested that although patient preference or refusal of surgery 
were often stated as possible reasons for variation in treatment, it may actually reflect 
clinician preference influencing communication of treatment options and how these are 
presented to the patient. The present study found that not all patients are offered a choice of 
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treatment and a significant proportion of treatment decisions were doctor-centred (Table 3). 
This may reflect current guidelines suggesting PET should not be used unless patients are 
deemed unfit for surgery, have significantly reduced life-expectancy or refuse surgery 
[31,32]. However, it is recognised that for some patients, quality of life is more important 
than quantity [33], and it may be appropriate to offer PET as an alternative to surgical 
treatment, allowing the patient to decide their preferred treatment option. This principle also 
fits with the current drive for more shared DM in healthcare, which requires treatment 
alternatives to be discussed with patients.  
For those offered choice, a small number of patients wanted a recommendation from their 
HCP, and Schonberg and colleagues found this to be the most influential factor affecting 
older women’s breast cancer treatment decisions [25]. However not all HCPs are comfortable 
recommending a treatment plan, choosing instead to encourage the patient to decide. 
Encouraging an active role in DM when patients prefer a more passive role may increase 
anxiety and cause distress [34,35]. 
Healthcare professionals did not feel that older patients wanted as much information as their 
younger counterparts, however, for patients this varied, with some appreciating more detailed 
information on treatment choices. This is in keeping with Elkin and colleagues who found 
that despite some older people not wishing to take an active role in the DM process, they still 
wanted to receive information about the treatment option available [36]. Even when patients 
do not wish to take an active role in decisions they may seek information as a method of 
coping with and taking control of breast cancer [37,38].  
Although most HCPs unsurprisingly felt that patients needed adequate time to consider their 
treatment options and make decisions, this was in complete contrast to the patients' 
perception who tended to feel internal pressure to make a decision quickly, this being in line 
with previous studies [39,40]. Additionally, some patients felt pressured to take a decision 
quickly as they believed it was expected by the HCPs. 
It is acknowledged that retrospective interview studies, particularly involving older people, 
may be subject to inaccurate recall of events and details. However many themes were 
common findings between women and HCPs, giving confidence in the data. Combined with 
the prospectively collected questionnaire data, the mixed methods approach allows the 
questionnaire data to expand on the qualitative findings, giving a broader overview of this 
problem. 
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Our findings support an individualised approach to treatment DM for older women with 
operable breast cancer, including the discussion of alternative treatment options, which may 
come with the caveat that one option is considered superior. A decision aid which includes 
more information on the treatment options and outcomes in this population may be helpful to 
both patients and HCPs to improve concordance in the DM process. This study also 
highlights the need for further research on the DM process and its relationship to decision 
regret in this setting.  
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Table 1: Questionnaire options for preferred and actual DM styles [27,28]. 
 Preferred DM style Actual DM style DM Classification 
1 I prefer to leave all decisions regarding my treatment 
to my doctor 
My doctor made all the decisions regarding my 
treatment 
Doctor-centred DM 
2 I prefer that my doctor makes the final decision about 
which treatment will be used, but seriously considers 
my opinion 
My doctor made the final decision about which 
treatment was used, but seriously considered my 
opinion 
3 I prefer that my doctor and I share responsibility for 
deciding which treatment is best for me 
My doctor and I shared the responsibility for deciding 
which treatment was best for me 
Shared DM 
4 I prefer to make the final selection of my treatment 
after seriously considering my doctor’s opinion 
I made the final selection of my treatment after I had 
seriously considered my doctor’s opinion 
Patient-centred DM 
5 I prefer to make the final selection about which 
treatment I will have 
I made the final selection about which treatment I had 
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Table 2: Comparison between patients' preferred and actual decision style. 
Preferred decision style Actual DM style Total 
Doctor-centred Shared Patient-centred 
Doctor-centred 198 28 21 247 
Shared 61 178 45 284 
Patient-centred 16 22 160 198 
Total 275 228 226 729 
Agreement = 73.5%; Kappa = 0.60, p<0.001; agreed values in bold 
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Table 3: Representative quotes from interviews comparing HCP and patients views. 
 HCP views Patient views 
Theme 1: Patient involvement in DM 
Subtheme 1a: 
patients’ 
preconceived 
ideas 
“Some ladies will say at 70 ‘I’m too old to have an 
operation’.” (Female Nurse; High PET unit) 
“Well I am too old, 91 to go to a big operation like that.” 
(91yrs; PET) 
“The older woman who lives independently, they’d rather 
die than lose their independence... their priorities are very 
different... It’s not about survival... thorough treatment of 
their breast cancer may be something that they’re not 
actually interested in.” (Female Surgeon; High PET unit) 
“I was feeling okay and I thought if my quality of life is like 
this at the moment, if I can keep it like this for a couple more 
years, well, that’s okay with me, so that was my decision.” 
(81yrs; PET) 
 
“Usually when people hold such strong, seemingly 
irrational, views it’s usually because of an experience that 
they have had or an experience that a member of family 
or close friend has had.” (Male Geriatrician; High PET 
unit) 
“‘Do what you’ve got to do,’ we lost a daughter-in-law with 
breast cancer, she was only 26, and that’s 30 years ago… 
Cancer is the most frightening word.” (82yrs; Surgery) 
Subtheme 1b: 
DM styles 
“A lot of women in that age group have their own 
opinions and they can’t be changed” (Male Surgeon; Low 
PET unit) 
“I’d already made my mind up because I knew it was cancer 
– you know in my own mind and made my mind up that I was 
having the breast taken off” (81yrs; Surgery) 
“Some women really don’t want to make that decision, 
they think it’s the sort of thing that a doctor should do” 
(Female Surgeon; High PET unit) 
“..[Dr] deals with that all day and every day so I just said 
‘Well what do you advise?’ And I mean because he knew 
about it, I just took his advice.” (81yrs; Surgery) 
Theme 2: Influence of HCP on DM 
Subtheme 2a: 
Impact of HCP 
view on DM 
“it’s the way you… sell something and personal opinion 
comes into it… a surgeon might think they know best and 
patients obviously listen to their doctor” (Female Nurse; 
Low PET unit) 
“I think she [Dr] played a big part, because she put it so 
clearly that it was easy to make a decision” (89yrs; PET) 
 
“I said ‘well I’m not taking tablets, I’m going to have my 
breast off’… he [Dr] said ‘but I’m very reluctant’ he said 
‘you’re 94 year old’.” (94yrs; Surgery). 
Subtheme 2b: 
Offering a choice 
“The literature suggests… they should be offered an 
operation and so that’s what I offer them. So I don’t give 
them a choice between surgery and PET” (Male Surgeon; 
Low PET unit) 
“P: I wasn’t given a choice, no. 
I: No, would you have liked a choice? 
P: I think I would really. I don’t know what I would of 
chosen though thinking about it.” (80yrs; PET) 
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Subtheme 2c: 
Making 
recommendations 
“If they ask me well what do I think, I will tell them… 
‘You choose what is right for you, not what is right for 
me… I don’t know how I will choose if I was sitting where 
you’re sitting so it really is your choice’.” (Female 
Surgeon; High PET unit) 
“My son said to him… ‘if it was your wife what would you 
recommend her to do’ and he said ‘I can’t answer that… it’s 
your mother’s decision. She has to decide for herself’.” 
(75yrs; Surgery) 
“I certainly tell them which is the preferable option” 
(Male Surgeon; High PET unit) 
“What would happen if I don’t have treatment? And… the 
doctor actually did say to me, ‘your other option is to have 
nothing done… but I wouldn’t recommend that’…” (81yrs; 
PET) 
Theme 3: Processes of DM 
Subtheme 3a: 
Timing of DM 
“Giving them time to think through it, the pros and cons, 
is very important” (Female Surgeon;  
Low PET unit) 
“Get rid of it. And see you don’t have time, because you 
want it done there and then. So you don’t have a lot of time 
to think about it.” (81yrs; PET) 
Subtheme 3b: 
HCP involved in 
DM process 
“She [nurse] does all the decision-making with them. 
They go into a room with her, I just tell them what it is 
and what the options are and over to the Breast Care 
Nurse.” (Male Surgeon; Low PET unit) 
“It was when the nurse took us into a separate room away 
from Dr [name] we thrashed this out” (85yrs; PET) 
Subtheme 3c: 
Information 
requirements 
“A lot of the older population, I feel, don’t want 
information” (Female Nurse; High PET unit) 
“They weren’t very forthcoming with information” (75yrs; 
PET) 
 
“why would you need all the other information? It’s only 
extra worrying” (81 yrs; PET) 
 
 
